Organogenesis Holdings (ORGO) Gross Margin Growth (5y) (2022 - 2026)

Organogenesis Holdings (ORGO) Gross Margin Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Organogenesis Holdings 310.55 Mn 218.45 Mn 11.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4,437.00
Dec 31, 2025 177.00
Sep 30, 2025 -125.00
Jun 30, 2025 171.00
Mar 31, 2025 308.00
Dec 31, 2024 5,205.00
Sep 30, 2024 5,634.00
Jun 30, 2024 5,627.00
Mar 31, 2024 5,384.00
Dec 31, 2023 -33.00
Sep 30, 2023 1,460.00
Jun 30, 2023 1,729.00
Mar 31, 2023 1,615.00
Dec 31, 2022 743.00
Sep 30, 2022 886.00
Jun 30, 2022 654.00
Mar 31, 2022 757.00